The diffuse expression of CD45, CD33, CD43, and BCL-2 in our case was instrumental in confirming the myeloid origin and ruling out other hematolymphoid or mesenchymal neoplasms. This evidence concerns the gene SPN and mesenchymal cell neoplasm.